Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Another major market introduction for Bayer's statin

Feb. 19, 1998

SBIR grant goes to OSI for diabetes research

Feb. 18, 1998

New HRT option now available for Canadian women

Feb. 18, 1998

Effects of RX-871024 on Ca2+ evaluated in mouse pancreatic beta-cells

Feb. 17, 1998

Natural insulin secretagogue with potential in NIDDM

Feb. 17, 1998

rhIL-11 sees first launch

Feb. 17, 1998

SmithKline Beecham discovers nonpeptide G-CSF mimetics

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

Hypocholesterolemic agents disclosed by Warner-Lambert

Feb. 16, 1998

New antiobesity agent now being distributed in U.S.

Feb. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...